Publications

Demonstrating multi-country calibration of a tuberculosis model using new history matching and emulation package - <i>hmer</i>.

Scarponi, D; Iskauskas, A; CLARK, R; Vernon, I; McKinley, T; Goldstein, M; Mukandavire, C; Deol, A; WEERASURIYA, C; Bakker, R; WHITE, R; MCCREESH, N;

2022

medRxiv (2022). 10.1101/2022.05.13.22275052.

Effectiveness of a pay-it-forward intervention compared with user-paid vaccination to improve influenza vaccine uptake and community engagement among children and older adults in China: a quasi-experimental pragmatic trial.

WU, D; Jin, C; Bessame, K; Tang, FF-Y; Ong, JJ; Wang, Z; Xie, Y; JIT, M; LARSON, HJ; CHANTLER, T; LIN, L; Gong, W; Yang, F; Jing, F; Wei, S; Cheng, W; Zhou, Y; Ren, N; Qiu, S; Bao, J; Wen, L; Yang, Q; Tian, J; Tang, W; TUCKER, JD;

2022

The Lancet Infectious diseases, (2022).22 10 10.1016/S1473-3099(22)00346-2.

Evolving measles status and immunization policy development in six European countries.

Vojtek, I; LARSON, H; Plotkin, S; Van Damme, P;

2022

Human vaccines & immunotherapeutics, (2022).18 1 10.1080/21645515.2022.2031776.

Updating age-specific contact structures to match evolving demography in a dynamic mathematical model of tuberculosis vaccination.

WEERASURIYA, CK; Harris, RC; MCQUAID, CF; Gomez, GB; WHITE, RG;

2022

PLoS Computational Biology, (2022).18 4 10.1371/journal.pcbi.1010002.

ISIDLSHTM/Model_Size_Selection.

BENEST, J; Rhodes, S; Evans, TG; WHITE, RG;

2022

, Github (2022).

Tailoring immunisation programmes in a time of SARS-CoV-2: What can be learnt by comparing the findings of childhood and COVID-19 vaccine evaluation studies in an underserved population?.

KASSTAN, B; Letley, L; MOUNIER-JACK, S; Klynman, N; GASKELL, KM; EGGO, RM; MARKS, M; CHANTLER, T;

2022

Public health in practice, (2022).4, 10.1016/j.puhip.2022.100287.

WHO preferred product characteristics for monoclonal antibodies for passive immunization against respiratory syncytial virus (RSV) disease in infants - Key considerations for global use.

Sparrow, E; ADETIFA, I; Chaiyakunapruk, N; Cherian, T; Fell, DB; Graham, BS; Innis, B; Kaslow, DC; Karron, RA; Nair, H; Neuzil, KM; Saha, S; SMITH, PG; Srikantiah, P; Were, F; Zar, HJ; Feikin, D;

2022

Vaccine, (2022).40 26 10.1016/j.vaccine.2022.02.040.

Engineering a suite of E. coli strains for enhanced expression of bacterial polysaccharides and glycoconjugate vaccines.

KAY, EJ; MAURI, M; WILLCOCKS, SJ; SCOTT, TA; CUCCUI, J; WREN, BW;

2022

MICROBIAL CELL FACTORIES, (2022).21 1 10.1186/s12934-022-01792-7.

Estimating the contribution of transmission in primary healthcare clinics to community-wide TB disease incidence, and the impact of infection prevention and control interventions, in KwaZulu-Natal, South Africa.

MCCREESH, N; Karat, AS; GOVENDER, I; BAISLEY, K; Diaconu, K; Yates, TA; HOUBEN, RM; Kielmann, K; GRANT, AD; WHITE, R;

2022

BMJ global health, (2022).7 4 10.1136/bmjgh-2021-007136.

Health impact of routine measles vaccination and supplementary immunisation activities in 14 high burden countries: a DynaMICE modelling study.

Auzenbergs, M; FU, H; Abbas, K; PROCTER, S; Cutts, F; JIT, M;